PCK Financial Statements | Balance Sheet, Income & Cash Flow Analysis
The financial statements for PCK (PCK) provide a snapshot of revenue trends, balance-sheet strength, and cash flow quality. Reviewing these together helps investors evaluate earnings durability, capital structure, and whether operating cash flow supports long-term business growth.
See stock fair value and complete historical financials—premium unlocks deeper tables and metrics.
Financial Statements
Related peers
Compare More →| MDR MedAdvisor Limited | $0.02 +0.00% |
| ALC Alcidion Group Limited | $0.10 +0.00% |
| M7T Mach7 Technologies Limited | $0.30 -3.23% |
| DOC Doctor Care Anywhere Group PLC | $0.14 +0.00% |
| ICR Intelicare Holdings Limited | $0.02 +0.00% |
| PAR Paradigm Biopharmaceuticals Limited | $0.22 -4.35% |
| Peer | Price | Change | Market Cap | PE | EPS | Div Yield (TTM) | Analyst Rating | Volume |
|---|---|---|---|---|---|---|---|---|
| MDR MedAdvisor Limited | $0.02 | +0.00% | 14.00 M | -0.20 | -0.11 | 0.00% | Hold | 59 |
| ALC Alcidion Group Limited | $0.10 | +0.00% | 134.30 M | -10.00 | -0.01 | 0.00% | Buy | 39 |
| M7T Mach7 Technologies Limited | $0.30 | -3.23% | 70.50 M | -7.50 | -0.04 | 0.00% | Buy | 143 |
| DOC Doctor Care Anywhere Group PLC | $0.14 | +0.00% | 49.50 M | 13.50 | 0.01 | 0.00% | Hold | 78 |
| ICR Intelicare Holdings Limited | $0.02 | +0.00% | 10.87 M | -2.30 | -0.01 | 0.00% | — | 1.94 |
| PAR Paradigm Biopharmaceuticals Limited | $0.22 | -4.35% | 99.39 M | -2.20 | -0.10 | 0.00% | Buy | 2.73 |
Frequently Asked Questions
What are PCK's latest financial results?
Review PCK's latest balance sheet, income statement, and cash flow to understand its profitability, revenue trends, and financial health. These metrics are essential for evaluating short-term performance and long-term stability.
How has PCK's revenue and net income changed over time?
Analyzing historical revenue and net income shows growth trends and business performance. Consistent growth indicates operational strength, while declines may signal challenges that investors should consider.
What is PCK's cash flow situation and liquidity?
Cash flow statements reveal how PCK generates and uses cash. Strong operating cash flow and sufficient liquidity suggest the company can fund operations, pay dividends, and handle debt effectively.
How does PCK's financial performance compare to industry peers?
Comparing key metrics like revenue growth, profit margins, and debt levels with competitors helps investors assess whether PCK is outperforming or lagging within its sector.
Are PCK's financial statements showing sustainable profitability?
By analyzing margins, ROE, ROIC, and cash generation over multiple periods, investors can evaluate whether PCK's profits are repeatable and supported by strong fundamentals.